Please find enclosed herewith Statement of Deviation or Variation for the half year ended September 30, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Acceleratebs India has filed a routine compliance statement confirming that the proceeds from its July 2023 public equity issue were used exactly as originally planned, with no deviation. The company raised Rs. 1.69 crore gross (Rs. 1.43 crore net after issue expenses of Rs. 27.15 lakh). Of the net proceeds, Rs. 1.09 crore was used for long-term working capital needs and Rs. 33.98 lakh for general corporate purposes — both fully deployed as intended. The Audit Committee reviewed and approved the statement on November 10, 2025, and the auditors raised no comments.
This is a positive, routine compliance disclosure that signals good governance and disciplined fund usage. It should have no material impact on the stock price but reassures shareholders that IPO money was spent as promised.